Editor's note: Seeking Alpha is proud to welcome GG Pharma Research as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA Essential. Click here to find out more »
TrovaGene, Inc. (TROV) is a promising therapeutics company. In our view, TrovaGene’s results and the number of product candidates in the pipeline make the company a must-follow. With that, the company’s main problem is stock dilution. TrovaGene has sold a significant amount of shares in the